Clinical

Featured

The Fit-for-Purpose Gap: What RWD Still Gets Wrong

In this session, industry experts Dr. Radek Wasiak and Isabella Even-Chen break down the critical "Fit-for-Purpose Gap"—the misstep of assuming a single, generalized dataset can satisfy every study design, regulatory requirement, or health economics endpoint.

Highlight

Clinical

The Fit-for-Purpose Gap: What RWD Still Gets Wrong

Heading

From Clinical Data to Actionable Assets for Pharmaceutical R&D

Precision in Human Biological Samples: Leveraging Regulatory Rigor and Deep Data for Advanced Disease Research

Filling the Gap: Integrating Patient-Generated Data into Real-World Evidence

Heading

The Trials of Rare Disease Clinical Research

3 Ways Big Data Could Benefit Pharma and Biotech

The Way to Patient-Centered Outcomes Research - Part 3

Patient-Reported Outcomes in Cancer Management - Part 2

Patient-Centered Outcomes in the Clinic - Part 1

How are Patient Decisions Formed to Stay or Drop Out of a Clinical Trial?

Taking Business Overseas: Why Pharma Is Staying in Asia

Contract Research Map Updated!

Contract Research Maps

Scientist Webinar Schedule Update

Drug Discovery Goes Global: Location of CROs Around the World

How to Run a Successful Research Lab Without Having a Lab

Scientist Supports the Scientific Community

The Value of Private CRXs

Using Scientist for Contract Pharmaceutical Research Outsourcing

Reducing, Refining and Replacing the Use of Animals in Research

Biomarkers Before the Assay: Sample Strategy and Signal Integrity

From Clinical Data to Actionable Assets for Pharmaceutical R&D

Beyond Exposure: Integrating PK/PD for Translational Predictive Power

Advancing ADC Development: Leveraging AI and Translational Preclinical Models to Improve Clinical Predictability

Using ALS Patient-Derived Motor Neurons to Study TDP-43 Mislocalization

Transcranial Focused Ultrasound Neuromodulation of the Default Mode Network in the Treatment of Depression and Promotion of Wellness

Artificial Intelligence in Preclinical Research: Pathology, Biospecimens, and Model Selection

Network meta-analysis and its role in evidence-based decision-making

Biomarkers from Bench to Bedside: Tools, Targets, and Translational Insights

Breaking the Bottleneck: Harnessing Proteomics Services to Overcome Challenges in Clinical Research

Addressing Orphan and Rare Diseases - A Cutting Edge Conversation

Joint Clinical Assessment 2025: Pioneering Pathways for Oncology, Advanced Therapies & Rare Diseases

RWE reality check: Routine patient health records and regulatory requirements

Migraine: Past, Present, and Future

Pathophysiology of Endometriosis: Current Concepts and Clinical Translations

Indirect Calorimetry for Rodent Research: New Approaches to Enhance Translational Value

Licensing Biological Materials: Crucial Considerations for Preclinical Researchers

Spatial Biology and the Gastrointestinal Tract: Unveiling Cellular Landscapes and Disease Mechanisms

Meeting Ethical & Regulatory Requirements When Using Human Biological Specimens

From Bench to Clinic: Decoding the IND Roadmap for Innovative Cell and Gene Therapies

The Role of Advanced De-Identification in AI-Driven Healthcare

Survival Analysis for Immature Data: A Review of Techniques and Lessons Learned

Market Access - Transforming BioTech Commercial Decisions?

Illuminating Immunohistochemistry: From Biomarker to Clinical Trial Assay

The Translational Utility of Ultrasound and Photoacoustics in Head and Neck Oncology

Delphi Panels: What Are They Good For?

Unraveling European Animal Welfare Legislation for Biotech & Pharma

Patient Voices Matter: Transforming Industry-Sponsored Real-World Evidence with Patient-Centric Approaches

Understanding Animal Welfare Best Practices in Asia Pacific for Biotech & Pharma

Updates in Chronic Traumatic Encephalopathy (CTE)

Strategies to Optimize Commercialization of Oncology Treatments for Younger Adults

Navigating Animal Welfare Legislation in North America: Insights for Biotech & Pharma

Compensatory Mechanisms in Parkinson's Disease

Navigating the Clinical Outcomes Maze: An Overview of Clinical Outcomes Assessments and Why Training Matters

EU HTA Joint Clinical Assessments: Navigating Potential Challenges Ahead of 2025

Cell & Gene Therapies - Beginning with the End in Mind

From Models to Heartbeats: Computational Design of Vagus Nerve Stimulation for Cardiac Health

Bridging the Gap: Strategies for Patient-Centered Real-World Evidence in Rare Diseases

Implantable Circuit-Specific Treatments for Autonomic Dysfunction

Integrating Patient Engagement and Trainee Development in Pre-Clinical Research

Voices to Trials: Engaging Patients in Clinical Trial Design

Partnering with Disease Registries: The Value and Impact for Real-World Evidence Generation

Minimizing the Impact of Cross-Cultural Differences in COA Translations

Transforming clinical research: Scaling real-world data across diseases with expert-led AI

Improving Patient Outcomes: AI-Based Phenotyping for Diagnosis, Treatment, and Clinical Trials

Clinical Trial Innovation: How Healthcare Technology is Evolving

COMPLi HBS Legislation Series: France

Notice of Pre-Application Webinar for RFA-AG-24-009, "Alzheimer's Disease (AD) and AD-Related Dementias (ADRD) Real-World Data Platform (U54 Clinical Trial Optional)"

Economic Impact of Representativeness in Clinical Trials: How Real-World Data Can Help

Connecting Real-World Data and Domain Expertise to Enhance Trial Design and Planning

How to Supercharge Real World Evidence Generation in Phase IV Trials

Keeping pace with the evolving global landscape in vaccine development

Patient centric sampling in pediatric clinical trials- successes, challenges and how to overcome them

Decentralized trial solutions for complex clinical trials

Social Media Data: Opportunities and Insights for Clinical Research

Achieving Consensus When Everyone is an Expert, but No One Agrees

Overcoming Patient Recruitment Challenges in Rare Disease Trials - September 28th